LOS ANGELES, Sept. 11, 2007 (PRIME NEWSWIRE) -- Universal Detection Technology (OTCBB:UDTT)(www.udetection.com), a developer and marketer of early-warning monitoring technologies to protect people from bioterrorism, announced today that it has received a purchase order from the government of England. The order is for consumables and software for two of the Company's BSM-2000 anthrax detection systems previously purchased by the British Government. The order also includes point detection kits which are capable of detecting anthrax, Ricin toxin, Botulinum toxin, plague, and SEBs.
"We are very pleased to have reached this milestone. The British Government was the first customer for our BSM-2000 product line and we are excited to have received a new order from them for additional consumables and software for their systems. We are also pleased to have the opportunity to supply them with our point bioterrorism detection kits," said Jacques Tizabi, UDTT's Chief Executive Officer.
A recent video featuring the Company and its BSM-2000 Anthrax Detection System can be viewed by going to: http://www.udetection.com/pressroom-video-NBC1006.htm.
For more information please visit www.udetection.com or
Email us at info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.